Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Phase 3 Sugar Controller Reduces Insulin and Glucose Impact to Sucrose - Nutraceuticals World

What are you searching for?

Sign in
Research

Phase 3 Sugar Controller Reduces Insulin and Glucose Impact to Sucrose

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Results of both pilot and clinical studies recently showed that Phase 3 Sugar Controller, a patent-pending, proprietary combination of a specific form of L-arabinose and a patented form of chromium, significantly reduced both blood glucose and insulin responses to sucrose challenges, according to Pharmachem Laboratories, developer of the ingredient.

The pilot study of 20 healthy, non-diabetic subjects showed that taking Phase 3 Sugar Controller led to an average reduction in glucose of 31%, and an average reduction in insulin of 32% when presented with a 70 gram sucrose challenge. In the two-phase clinical trial of 50 healthy non-diabetic adults, subjects taking Phase 3 Sugar Controller had an average reduction in glucose of 24.3% and an average reduction in insulin of 28.2% when faced with the same sucrose challenge. The studies have been submitted for publication. For further information: www.pharmachemlabs.com

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters